Innospec SVP awarded 1,730 shares in Form 4
INNOSPEC INC. senior vice president Corbin Barnes reported an equity award in company stock.
Rhea-AI Filing Summary
INNOSPEC INC. senior vice president Corbin Barnes reported an equity award in company stock. On February 16, 2026, he acquired 1,730 shares of common stock at a stated price of $0.00 per share through the settlement of a performance-based restricted stock unit award granted on February 27, 2023.
After this grant, Barnes directly holds a total of 10,764.6117 shares of Innospec common stock. The transaction reflects equity compensation rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,730 shares
Grant/Award
1 txn
Insider
BARNES CORBIN
Role
SVP, Corporate Dev and IR
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,730 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 10,764.6117 shares (Direct)
Footnotes (1)
- F1. Shares of common stock acquired upon settlement of a performance-based restricted stock unit award granted to the reporting person on February 27, 2023.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Innospec (IOSP) report for Corbin Barnes?
Innospec reported that SVP Corbin Barnes acquired 1,730 shares of common stock. The shares were delivered at a stated price of $0.00 per share upon settlement of a performance-based restricted stock unit award originally granted on February 27, 2023, increasing his direct holdings.
Was the latest IOSP Form 4 a stock purchase or an equity award?
The IOSP Form 4 reflects an equity award, not an open-market stock purchase. Corbin Barnes received 1,730 common shares at a stated price of $0.00 per share from settling a performance-based restricted stock unit grant dated February 27, 2023.
Does the Innospec (IOSP) Form 4 indicate any stock sale by Corbin Barnes?
The Form 4 does not report any stock sale by Corbin Barnes. It shows a grant or award acquisition of 1,730 shares of common stock upon settlement of a performance-based restricted stock unit award, increasing his directly held Innospec share balance to 10,764.6117.
AI-generated analysis. How Rhea-AI works. Not financial advice.